Global Urolithiasis Management Devices Market, By Treatment Type (Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy, Others), Product Type (Lithotripters, Ureteroscopes), End User (Hospitals and Clinics, Ambulatory Surgical Centers) – Industry Trends and Forecast to 2029.
Urolithiasis Management Devices Market Analysis and Size
Urinary stones are widespread throughout the world, with a global target population of 15% and a recurrence rate of 50%. Men are more likely than women to develop kidney stones. The increasing introduction of new and innovative devices for treating urolithiasis and the laser crushers and flexible ureteroscopes for renal stone disease also contribute to the healthy growth of the urolithiasis management devices market.
Data Bridge Market Research analyses that the urolithiasis management devices market which was valued at USD 1.48 billion in 2021, would rocket up to USD 2.34 billion by 2029, and is expected to undergo a CAGR of 5.90% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Urolithiasis Management Devices Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Treatment Type (Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy, Others), Product Type (Lithotripters, Ureteroscopes), End User (Hospitals and Clinics, Ambulatory Surgical Centers)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Market Players Covered
|
Allengers (India), Boston Scientific Corporation (U.S.), BD (U.S.), Cook (U.S.), CONMED Corporation (U.S.), DirexGroup (Germany), Dornier MedTech (Germany), Karl Storz GmbH & Co. K.G. (Germany), Potent Medical (China), HealthTronics, Inc (U.S.), Olympus Corporation (Japan), EMS (Switzerland)
|
|
Market Opportunities
|
|
Market Definition
Urolithiasis means that stones form primarily in the urinary system, such as the kidneys, ureters, and bladder. Small stones generally do not require surgical intervention and can be cured with the help of medicines and a healthy diet. However, removing large stones requires various steps. Many patients with urolithiasis can be managed with careful follow-up, analgesics, and antiemetics. However, stones associated with obstruction, renal failure, and infections require even more important intervention.
Global Urolithiasis Management Devices Market Dynamics
Drivers
- Increased prevalence of urinary stones and their higher recurrence rate
Globally, the prevalence of urolithiasis has increased in both developed and developing countries over the last few decades, leading to an increase in the prevalence and recurrence of kidney stones. This growth trend is thought to be related to lifestyle-related changes such as sedentary lifestyles, eating habits, and global warming.
- Increasing adoption of the minimally invasive stone removal procedure
High acceptance of common minimally invasive techniques and their minimal side effects compared to open surgery for renal stones, bladder stones, extracorporeal shock wave stone crushing, internal stone crushing, and percutaneous renal stones drives the future, which may increase the demand for advanced procedures for devices for treating urolithiasis. According to the Journal of Advances in Chronic Kidney Diseases, minimally invasive treatments have been used primarily for nephrolithiasis, extracorporeal shock wave lithotripsy, internal lithotripsy, and percutaneous nephritis. In addition, surgeons use minimally invasive surgery, which was performed as open surgery.
Opportunities
- Launch of New Products
The launch of new satellite offices for urology care is likely to fuel the growth of the urolithiasis management devices market. For instance, in July 2020, Advanced Urology started new satellite offices in Buckhead, Canton, Braselton, and Cumming to offer urology care.
Restraints/Challenges
- Risk of Infection
There are high risks associated with adopting these devices, which in turn poses a major hindrance in lowering the market growth of urolithiasis management devices.
This urolithiasis management device market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the urolithiasis management device market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Global Urolithiasis Management Devices Market
The Covid-19 pandemic had a negative impact on the urinary stone treatment device market, resulting in a decline in market sales. Many small hospitals and elderly housings had to be temporarily closed due to blockades. In addition, during this period, limited availability of urolithiasis devices, sluggish manufacturing of medical devices, and economic stagnation were apparent.
Recent Developments
- In July 2020, Lumenis Ltd. launched MOSES 2.0, the next generation of the versatile, patented MOSES platform for urology care.
- In June 2020, Olympus Corporation launched a new application of thulium fiber technology named Soltive SuperPulsed Laser System (Soltive Laser System). It is designed for stone lithotripsy and soft tissue applications.
Global Urolithiasis Management Devices Market Scope
The urolithiasis management devices market is segmented on the basis of treatment type, product type, and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Treatment Type
- Extracorporeal Shock Wave Lithotripsy (ESWL)
- Intracorporeal Lithotripsy
- Percutaneous Nephrolithotomy
- Other Treatments
Product Type
- Lithotripters
- Intracorporeal
- Extracorporeal
- Ureteroscopes
- Semi rigid
- Flexible
End-User
- Hospitals and Clinics
- Ambulatory Surgical Centers
Global Urolithiasis Management Devices Market Regional Analysis/Insights
The urolithiasis management devices market is analysed and market size insights and trends are provided by country, treatment type, product type, and end-user as referenced above.
The countries covered in the urolithiasis management devices market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the urolithiasis management devices market rapid rise in the campaign by government agencies to raise patient awareness in areas of increased prevalence of kidney stones, an increasing elderly population, and risks associated with kidney stones.
Asia-Pacific is projected to grow at a significant growth rate over the forecast period of 2022 to 2029 due to increased medical costs for devices to treat urolithiasis from emerging markets such as India and China, as well as an increase in the number of kidney stone cases in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Global Urolithiasis Management Devices Market Share Analysis
The urolithiasis management devices competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to urolithiasis management devices market.
Some of the major players operating in the urolithiasis management devices market are:
- Allengers (India)
- Boston Scientific Corporation (U.S.)
- BD (U.S.)
- Cook (U.S.)
- CONMED Corporation (U.S.)
- DirexGroup (Germany)
- Dornier MedTech (Germany)
- Karl Storz GmbH & Co. K.G. (Germany)
- Potent Medical (China)
- HealthTronics, Inc (U.S.)
- Olympus Corporation (Japan)
- EMS (Switzerland)
SKU-